The Commish said:
matttyl said:
The Commish said:
matttyl said:
TobiasFunke said:
The government is the one that enables their high prices in the first place by giving them patent protection.
Are you saying that Rx companies shouldn't have patent protection? I think their protection now last 20 years. I have a list of drugs getting a generic equivalent this year on my desk (as you know what it is I do). The big ones (the ones I recognize right off) are Crestor, Benicar, Vytorin, Strattera, and yes....Viagra - as well as a few other caner and HIV drugs.
He can speak for himself, but I took it to mean he's just pointing out one of the realities. Personally? I think 20 years is way too long in this industry to hold a patent like that. But, I'm not a big fan of health care being a "business" in the first place, so I am biased.
So lets say we shorten it to 10 years. Rx companies aren't stupid, they will just jack up their prices even more for those 10 years - making these potentially lifesaving drugs even more out of reach for many people. That's also just "one of the realities".Another reality is that the government (through the FDA) gets to decide what drugs even make it to the market in the first place.
Don't disagree....this is a big part of why I don't believe in a healthcare business. We don't need to be making money off of health care.
Ok, lets say we don't. Rx development goes to the government and they hire who they feel is the "best and brightest". Wouldn't current Rx companies then just move to other counties where they can continue to develop their drugs (and possibly hire the actual "best of the best" and pay them better), and profits? Huge potential tax base lost, right? Would the government then say that anything developed elsewhere wouldn't be allowed in the US? What if that recent hep B drug was developed elsewhere?
Wouldn't that just be another "reality"?
I doubt that would happen. The best of the best are here. We have top universities to feed the talent pipeline, great quality of life, the lowest upper-income tax rates, etc.
Where they gonna go? Especially if we remove them from the standard federal compensation system for scientists and pay them well; then all we'd be doing is removing the seven-figure executives who contribute nothing to the process and the bloated marketing costs associated with running constant boner pill ads during sporting events and sending out an army of smoking hot chicks to buy steak dinners for doctors. Hell we still get a ton of innovation out of NIH and NSF already, without taking steps to incentivize them. We're not talking about a field where the feds lag way behind the private sector here, right?